hVIVO

Launch of hLAB standalone services

  • Sep 30 2024, 08:23 IST/BST
  • Colin Grant
  • Company Report
  • 6 page(s)
  • Sectors : Pharma and healthcare
  • Companies : hVIVO

Ratings and price correct at time of issue.

  • hVIVO

    Closing Price: 28.4p

  • RATING 11/10/23

  • PREVIOUS RATING 17/02/20

    UNDER REVIEW

Person's Name

Colin Grant

Analyst

DAVY VIEW

hVIVO has announced the launch of its hLAB service offering. This is a standalone business that it can offer for virology and immunology services. It follows the tripling of the company’s laboratory capacity after the move to its new facility at Canary Wharf. It broadens and diversifies hVIVO’s revenue potential.

View full article

Download full report with analyst certification and important disclosures

Sep 30 2024, 08:23 IST/BST

Download